UPDATE : Wednesday, January 17, 2018
상단여백
Yuhan’s chemo combo YH24931 more effective than immunotherapy alone
Yuhan Corp.’s combination of chemotherapy with immunotherapy YH24931 has st...
by Nam Doo-hyun  |  2017-12-18 11:51
라인
‘Postmenopausal women in 50s shouldn’t take phytoestrogen’
Over-the-counter drugs and health functional foods to alleviate symptoms of...
by Nam Doo-hyun  |  2017-12-18 10:49
라인
3 Korean startups using AI to develop new drugs
Korea’s biopharmaceutical industry is increasingly adopting artificial inte...
by Marian Chu  |  2017-12-15 23:00
라인
Medytox, Hugel compete in botulinum toxin market
Medytox and Hugel have achieved a rapid growth in manufacturing botulinum t...
by So Jae-hyeon  |  2017-12-15 15:12
라인
Parkinson’s disease treatment Azilect in robust growth
Lundbeck Korea’s Azilect (ingredient: rasagiline) is performing well in Kor...
by So Jae-hyeon  |  2017-12-15 11:36
라인
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market
Ildong Pharmaceutical and Abbot Korea are likely to try on the rosuvastatin...
by Lee Hye-seon  |  2017-12-14 15:01
라인
Koreans in their 20s most susceptible to hepatitis A: study
New research shows nine out of 10 young adults in Korea do not have antibod...
by Marian Chu  |  2017-12-13 18:18
라인
MGmed to change name to Cancer Rop
Korean pharmaceutical MGmed decided to change the company’s name to Cancer ...
by Marian Chu  |  2017-12-13 18:14
라인
Syntekabio, CJ Healthcare agree to develop new drugs using AI
Syntekabio and CJ Healthcare have signed an agreement to co-develop a new i...
by Lee Han-soo  |  2017-12-13 17:17
라인
Daewoong’s liver drug Ursa to enter US market
Daewoong Pharmaceutical said it aimed to sell its flagship product Ursa, a ...
by So Jae-hyeon  |  2017-12-13 15:23
라인
Janssen says its multiple myeloma drug combo halves death risk
Janssen, a Johnson & Johnson division, said a combination therapy with DARZ...
by Marian Chu  |  2017-12-13 15:22
라인
Celgene, Bluebird Bio’s CAR-T therapy proves 94% response in P1 study
Bluebird Bio and Celgene posted phase 1 results of investigational drug bb2...
by Marian Chu  |  2017-12-13 14:30
라인
AstraZeneca to test Imfinzi on lung cancer patients
AstraZeneca is to conduct a clinical trial on anti-cancer immunotherapy Imf...
by Lee Hye-seon  |  2017-12-13 14:20
라인
Wholesalers sweat over drug companies’ forceful sales
Local wholesalers of pharmaceutical products are experiencing distress at t...
by So Jae-hyeon  |  2017-12-13 11:33
라인
Hanmi leads erectile dysfunction drug sales
Teva Pharmaceutical and Pfizer said Monday they will launch generic version...
by Marian Chu  |  2017-12-12 17:49
라인
Drugmakers lead job growth in manufacturing sector
The pharmaceutical industry has led the growth of jobs in the manufacturing...
by So Jae-hyeon  |  2017-12-12 15:12
라인
Korea approves Olumiant pills for treatment of rheumatoid arthritis
The government has approved Olumiant (ingredient: baricitinib), an oral med...
by Lee Hye-seon  |  2017-12-12 11:50
라인
Huons wins patent for oral medication of clarithromycin
Huons, a subsidiary of Huons Global, said Tuesday that it has acquired a pa...
by Lee Han-soo  |  2017-12-12 11:41
라인
JW Pharma unveils trial result for target anticancer treatment
JW Pharmaceuticals said Monday that it has presented phase 1a/1b clinical t...
by Lee Han-soo  |  2017-12-11 16:55
라인
Pfizer pays most to doctors for overseas academic events
Among multinational pharmaceutical companies, Pfizer Korea paid the largest...
by So Jae-hyeon  |  2017-12-11 16:28
여백
여백
여백
Back to Top